Southcook MS Support Group - #Attributes.pagetitle#
Home
About
Advocacy
Clinical Trials
Events
Medical
Meetings
Search
Go!
Saturday, May 17, 2008
Research
The latest research in Multiple Sclerosis.
Research Date
Research Topic
10-27-07
-
A National Campaign Promising Hope and Care
10-27-07
-
MS Clusters
08-26-06
-
FDA Approves Natalizumab's (Tysabri) Return To Market For Relapsing MS
08-26-06
-
Promise: 2010
03-24-06
-
Promise 2010
03-24-06
-
Focus on Stem Cell Research in Illinois
03-24-06
-
Research Findings Advancing Fight Against MS
11-30-05
-
Another reason to adhere to your disease modifying therapy
11-30-05
-
Researchers Report Cell Transplants Protect Brain Tissue in Mice with MS-Like Disease
09-12-05
-
Every Picture Tells a Story: MRIs and MS
05-21-05
-
Biogen Idec Suspends Marketing of Tysabri
update
05-14-05
-
MS Center Profiles
05-13-05
-
Making a Promise to a Future Free of MS
02-10-05
-
Study Tracks Long-Term Prognosis of Individuals With Relatively Mild MS
11-23-04
-
Early Treatment Of Multiple Sclerosis With Disease Modifying Therapies
11-22-04
-
Youth and MS
11-22-04
-
Children, Teens, and MS How Early MS Diagnosis Can Effect Young People
09-28-04
-
Study Tracks Long-Term Prognosis Of Individuals With Relatively Mild MS
08-28-04
-
CAM in MS: An Introduction
08-23-04
-
Coping with the Emotions of MS
08-16-04
-
Modest Link Between Stress and MS Attacks
08-16-04
-
New MS Research Commitment
05-21-04
-
RESEARCH ADVANCES IN MS REPORTED AT AMERICAN ACADEMY OF NEUROLOGY MEETING
05-18-04
-
Early Study Finds Oral Cholesterol Drug Zocor® Safe For MS; Larger Studies Needed
04-25-04
-
Study Confirms Disease Risk Level for Co-Twins When One Has Multiple Sclerosis
04-25-04
-
Novel Technology Tested for Making "DNA
04-25-04
-
Research Progress
04-22-04
-
Repair & Recovery: Remylenation
01-06-04
-
FDA Approves Pre-Filled Diluent Syringe for Betaseron®
12-28-03
-
Aging with Multiple Sclerosis:Unmet Needs in the Great Lakes Region
12-28-03
-
Study Reports Association Between Smoking and MS
12-01-03
-
Can A Blood Test Predict MS?
07-30-03
-
Cluster Studies at U of I, Rockford
07-29-03
-
New Findings in Neurology
06-11-03
-
Participants Sought At Multiple Sites For Clinical Trial Testing Campath® In Early, Active Relapsing-Remitting MS
03-14-03
-
Smallpox Vaccine Recommendations
03-12-03
-
Estriol Trials Show Reduction
01-02-03
-
Results Published From Clinical Trial Of Antegren
12-13-02
-
Summary Of Research Progress
11-22-02
-
Cholesterol Drug Lipitor® Improves MS-Like Disease In Mice
11-01-02
-
Perspectives From People Aging with MS
11-01-02
-
$15.4 Million Awarded for New MS Research Projects
11-01-02
-
No Link Between Hepatitis B Vaccination and MS
10-08-02
-
Early Studies Suggest Lipitor ® May Treat Animal Models of MS
10-05-02
-
Transplanting Blood Stem Cells to Treat MS
10-03-02
-
News of Clinical Trials
10-03-02
-
$119 Million Awarded for new MS Research Projects
10-01-02
-
Symposium Highlights Cognition
08-09-02
-
Revised FAA Guidelines on Traveling with Injectable Medications
08-07-02
-
Coping with Cognitive Dysfunction
08-07-02
-
Researchers Find High Levels of Antibodies Against
Epstein-Barr Virus in Persons with MS
08-07-02
-
Investigators Suggest Factors in Long-Standing MS Brain Lesions May Inhibit Myelin Repair
08-07-02
-
FDA Approves Rebif® for Relapsing Forms of MS
01-10-02
-
Researchers Uncover Protein that May Play a Crucial Role in MS Attacks and Progression
01-05-02
-
Promising Results Announced from Clinical Trial of Antegren® in MS
01-03-02
-
Revised Statement Concerning Ages of Onset of MS
Research
MS Centers & Clinics
Symptoms of MS
What is MS
FAQ
MS Facts
MS Myths
Send This To A Friend
Top Of Page
QUESTIONS/COMMENTS
© 1999-08 Please familiarize yourself with our
Disclaimer
prior to accessing any resources on this website. As always this material is provided as general educational information. It is not intended as advice for individual patients. Comments are based on professional experience and do not represent therapeutic recommendation or prescription. Please contact your physician for specific recommendations.